Essink M - Search Results

1

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.

Silling G, Fegeler W, Roos N, Essink M, Büchner T. Silling G, et al. Among authors: essink m. Mycoses. 1999;42 Suppl 2:101-4. Mycoses. 1999. PMID: 10865914 Clinical Trial.

2

Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia.

Hiddemann W, Essink ME, Fegeler W, Zühlsdorf M, Sauerland C, Büchner T. Hiddemann W, et al. Among authors: essink me. Cancer. 1991 Jul 1;68(1):9-14. doi: 10.1002/1097-0142(19910701)68:1<9::aid-cncr2820680103>3.0.co;2-u. Cancer. 1991. PMID: 2049760 Clinical Trial.

3

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.

Silling G, Fegeler W, Roos N, Essink M, Büchner T. Silling G, et al. Among authors: essink m. Mycoses. 1999 Dec;42 Suppl 2:101-104. doi: 10.1111/j.1439-0507.1999.tb00023.x. Mycoses. 1999. PMID: 29265621

4

Effect of antifungal therapy on hematological recovery after intensive antileukemic chemotherapy.

Essink ME, Hiddemann W, von Eiff M, Büchner T, van de Loo J. Essink ME, et al. Haematol Blood Transfus. 1990;33:558-9. doi: 10.1007/978-3-642-74643-7_100. Haematol Blood Transfus. 1990. PMID: 2323655 No abstract available.

5

Hepatosplenic candidiasis in acute leukemias.

von Eiff M, Essink M, Roos N, Schmidt H, Hiddemann W, Büchner T, van de Loo J. von Eiff M, et al. Among authors: essink m. Haematol Blood Transfus. 1990;33:555-7. doi: 10.1007/978-3-642-74643-7_99. Haematol Blood Transfus. 1990. PMID: 2323654 No abstract available.

6

Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies.

von Eiff M, Essink M, Roos N, Hiddemann W, Büchner T, van de Loo J. von Eiff M, et al. Among authors: essink m. Blut. 1990 Apr;60(4):242-8. doi: 10.1007/BF01728792. Blut. 1990. PMID: 2337685

7

[Clinical course and risk factors in patients with generalized mycoses].

von Eiff M, Essink M, Fegeler W, Schellong S, Schmidt H, Hiddemann W, Büchner T, van de Loo J. von Eiff M, et al. Among authors: essink m. Schweiz Med Wochenschr. 1988 Apr 23;118(16):584-91. Schweiz Med Wochenschr. 1988. PMID: 3381072 German.

8

High-dose cytosine arabinoside and mitoxantrone: preliminary results of a pilot study with sequential application (S-HAM) indicating a high antileukemic activity in refractory acute leukemias.

Hiddemann W, Büchner T, Essink M, Koch O, Stenzinger W, van de Loo J. Hiddemann W, et al. Among authors: essink m. Onkologie. 1988 Feb;11(1):10-2. doi: 10.1159/000216471. Onkologie. 1988. PMID: 3283619 Clinical Trial.

9

Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.

Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J. Hiddemann W, et al. Among authors: essink m. Ann Hematol. 1991 Jul;63(1):1-4. doi: 10.1007/BF01714952. Ann Hematol. 1991. PMID: 1715191

10

Accidental overdose of mitoxantrone in three patients.

Siegert W, Hiddemann W, Koppensteiner R, Büchner T, Essink M, Huhn D, Jung M, Marosi L, Martin T, Minar E. Siegert W, et al. Among authors: essink m. Med Oncol Tumor Pharmacother. 1989;6(4):275-8. doi: 10.1007/BF02985161. Med Oncol Tumor Pharmacother. 1989. PMID: 2559263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters